Novel Pyrimidine- And Triazine-Hepcidine Antagonists
申请人:Dürrenberger Franz
公开号:US20120202806A1
公开(公告)日:2012-08-09
The present invention relates to new hepcidin antagonists, pharmaceutical compositions containing them and the use thereof as a drug, in particular for the treatment of iron metabolism disorders such as, in particular, iron deficiency diseases and anaemia, in particular anaemia associated with chronic inflammatory disease (ACD: anaemia of chronic disease and AI: anaemia of inflammation).
Theoretical DFT and matrix isolation FTIR studies of 2-(1,2,4-triazolyl)phenol isomers
作者:Magdalena Pagacz-Kostrzewa、Magdalena Sałdyka、Maria Wierzejewska、Dmytro M. Khomenko、Roman O. Doroschuk
DOI:10.1016/j.cplett.2016.06.005
日期:2016.7
Abstract The structure, isomerization pathways and vibrational spectra of the important heterocyclic 2-(1,2,4-triazolyl)phenol molecule were investigated by DFTcalculations and matrixisolationFTIR spectroscopy. Among forty-five minima located on PES three isomers with intramolecular hydrogen bond O H⋯N, 2-TRP1, 1-TRP1 and 1-TRP2, are the most stable forms with the calculated abundance of 83.4%,